Sr Group Director, Clinical Pharmacology
Regeneron Pharmaceuticals
Tarrytown, New York
Dr. Kenneth Turner is a Sr. Group Director of Clinical Pharmacology for the General Medicines therapeutic area at Regeneron Pharmaceuticals. He and his team are leading the Clinical Pharmacology development efforts on Regeneron’s anti-COVID-19 monoclonal antibody programs, and are also responsible for biologics programs in the Neuroscience and Ophthalmology therapeutic areas. Prior to joining Regeneron, Dr. Turner held various roles over a 20-year span as a Clinical Pharmacologist, Clinical Leader (medical devices), and Experimental Medicine Leader at Johnson & Johnson, Bristol-Myers Squibb, and Novartis Pharmaceuticals.
Disclosure information not submitted.
Monday, October 17, 2022
9:00 AM – 9:30 AM ET
Monday, October 17, 2022
3:30 PM – 3:45 PM ET